ST
Serina Therapeutics Inc
🇺🇸XNYS.SERUnited StatesHealthcare
$2.41USDdown -0.04 (-1.63%)OpenEnd of day5:10 PM
Price$2.41-0.04 (-1.63%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- New York Stock Exchange . XNYS
- Type
- Stock
- ISIN
- US81751A1088
- CUSIP
- 81751A108
Company
- Employees
- 16
- Headquarters
- Huntsville, United States
- CEO
- Mr. Steven A. Ledger
Market
- Shares outstanding
- 15M
- Market cap
- $36.14M
Highlights
- Market cap
- $36.14M
- EPS LTM
- -$1.77
- P/E LTM
- -1.11
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $130K+154.9%up year on year
- Net income
- -$21.27M-2,164.86%down year on year
- Gross margin
- 43.08%+127.81%up year on year
- Free cash flow
- -$18.24M+8.3%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.